Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Glavni avtor: | Siddika, Khadiza |
---|---|
Drugi avtorji: | Ahmed, Syeda Maliha |
Format: | Thesis |
Jezik: | English |
Izdano: |
Brac University
2024
|
Teme: | |
Online dostop: | http://hdl.handle.net/10361/24296 |
Podobne knjige/članki
-
Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Izdano: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
od: Rattry, Faria Rahman
Izdano: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Izdano: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Izdano: (2024) -
Molecular biology : genes to proteins /
od: Tropp, Burton E.
Izdano: (2008)